Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6905 - 6912 of 12092 results

Six Questions and Answers About CMS’ Recommended Changes to 340B Medicare Reimbursement
July 17, 2017| Blog| Viewpoint

Health Care Weekly Preview from ML Strategies – Week of July 17, 2017
July 17, 2017| Blog| Viewpoint

Plan To Cut Legal Immigration Likely To Be Uphill Battle
July 17, 2017| News

Travel Ban Update
July 17, 2017| Alert| Viewpoint

The Dos and Don’ts Of Minimizing Risk For TCPA Liability
July 14, 2017| News

FDA Delays Enforcement of Prescription Drug Product Identifier and Related Requirements
July 13, 2017| Blog| Viewpoint

Opportunity Foreclosed: The International Entrepreneur Parole Rule May Die Before it Gets Out of the Gate
July 13, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
